ACORDA THERAPEUTICS$23.34
-0.02
| Last Trade: |
23.34 |
| Trade Time: |
May 16 3:45 PM Eastern Daylight Time |
| Change: |
-0.02 (-0.09 %) |
| Prev Close: |
23.36 |
| Open: |
23.39 |
| Bid: |
23.32 |
| Ask: |
23.34 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : -11% - ACOR has underperformed the S&P 500 by 10%
Get Trend Analysis
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
12/23/2011
|
PANEM SANDRA PHD
|
Director
|
1,282
|
$23.40
|
78.65%
|
|
12/1/2011
|
Blight Andrew
|
Chief Scientifc Officer
|
-7,000
|
$22.92
|
-11.34%
|
|
12/1/2011
|
COHEN RON
|
President and CEO
|
-16,500
|
$22.92
|
-5.12%
|
|
12/1/2011
|
LAWRENCE DAVID
|
Chief Financial Officer
|
-9,896
|
$22.92
|
-37.85%
|
|
12/1/2011
|
Sabella Lauren M
|
Exec. VP-Commercial Dvlpmnt
|
-4,364
|
$22.91
|
-13.91%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ACOR), click here.
-
The Sanofi/Genzyme combination isn't the only biotech M&A activity on the radar.
Read More »
-
Four names to watch in the healthcare space as their earnings are released Nov. 3.
Read More »
-
Biotech stocks traditionally fare well through recessions. We'll see if that holds true.
Read More »
Free Reports
|
|
